BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹13.39
- Market cap
- ₹11.76 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 42.0×Sector 45.9×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Annual Report
Venmax Drugs and Pharmaceuticals Limited has submitted its Annual Report for the Financial Year 2025-26, including the Notice for its 37th Annual General Meeting.
Other board meeting date announcements
All →ECS Biztech Board Meeting Date
ECS Biztech schedules a 4 November 2026 board meeting to approve September 2026 quarter and half-year standalone results. Trading window stays closed until 48 hours post-results.
Orchasp Board Meeting Date
Orchasp will hold a board meeting on November 11, 2026 to approve unaudited half-yearly results. The trading window stays closed until November 13, 2026.
Vintage Securities Board Meeting Date
Vintage Securities will hold a board meeting on 05 November 2026 to consider unaudited standalone half-yearly results for September 2026. The meeting date is advance notice and the trading window closes from 01 October 2026.
SVP Global Textiles Board Meeting Date
SVP Global Textiles schedules a 9 November 2026 board meeting to consider September 2026 quarter results. Trading window stays closed until 48 hours after results.
Krupalu Metals Board Meeting Date
Krupalu Metals gave prior intimation of its 4 November 2026 board meeting to approve unaudited results for the half year ended 30 September 2026. The filing also notes the trading window closure for insiders.
Capital Trade Links Board Meeting Date
Capital Trade Links Ltd informed BSE of a board meeting on November 4, 2026 to approve standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window for designated persons is closed until 48 hours after results.